Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 13,500 shares at $76.60 ($1.0M) on 2018-07-16, disclosed to the SEC on 2018-07-18.
Open-market sale of $1.0M RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.19 | 2,628 | $195K | 19.2% |
| 2 | $74.19 | 2,628 | $195K | 19.2% |
| 3 | $75.18 | 2,510 | $189K | 18.6% |
| 4 | $75.18 | 2,510 | $189K | 18.6% |
| 5 | $76.60 | 862 | $66K | 6.5% |
| 6 | $76.60 | 862 |
| $66K |
| 6.5% |
| 7 | $77.88 | 1,500 | $117K | 11.5% |
| Total | $75.28 avg | 13,500 | $1.0M | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |